Literature DB >> 22016838

Mechanisms of aneuploidy induction by RAS and RAF oncogenes.

Tamihiro Kamata1, Catrin Pritchard.   

Abstract

Most cancers progress with the accumulation of genetic mutations with time and this is frequently associated with the acquisition of genomic instability in the form of whole chromosome changes, chromosomal rearrangements, gene amplifications or smaller changes at the nucleotide level. Whole chromosome instability (W-CIN), characterised by aneuploidy, is a major form of genomic instability observed in human cancers and several lines of evidence now support the argument that W-CIN is a promoter of tumourigenesis rather than being a passenger event. The primary mechanism proposed for evolution of CIN is abnormalities in mitosis/cytokinesis. However, mutations in genes directly involved in controlling mitosis/cytokinesis are rare in human cancers and so the mechanisms underpinning the evolution of CIN in cancers are not currently clear. On the other hand, mutations in RAS or BRAF are frequently found in human cancers, many of which demonstrate CIN, suggesting a possible link between deregulated signaling through the RAS/RAF/MEK/ERK pathway and CIN. In this review, we focus on a potential relationship between deregulated RAS/RAF signaling and CIN, and discuss possible mechanisms connecting the two.

Entities:  

Keywords:  BRAF; CRAF; ERK; RAS; aneuploidy; cancer; genome instability; mouse models; oncogenes

Year:  2011        PMID: 22016838      PMCID: PMC3196290     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  120 in total

1.  Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.

Authors:  A Loonstra; M Vooijs; H B Beverloo; B A Allak; E van Drunen; R Kanaar; A Berns; J Jonkers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

2.  Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis.

Authors:  Mio Shinohara; Alexei V Mikhailov; Julio A Aguirre-Ghiso; Conly L Rieder
Journal:  Mol Biol Cell       Date:  2006-10-11       Impact factor: 4.138

3.  Chronophin, a novel HAD-type serine protein phosphatase, regulates cofilin-dependent actin dynamics.

Authors:  Antje Gohla; Jörg Birkenfeld; Gary M Bokoch
Journal:  Nat Cell Biol       Date:  2004-12-05       Impact factor: 28.824

Review 4.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

5.  Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.

Authors:  Wade S Samowitz; Carol Sweeney; Jennifer Herrick; Hans Albertsen; Theodore R Levin; Maureen A Murtaugh; Roger K Wolff; Martha L Slattery
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

6.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.

Authors:  T Kambara; L A Simms; V L J Whitehall; K J Spring; C V A Wynter; M D Walsh; M A Barker; S Arnold; A McGivern; N Matsubara; N Tanaka; T Higuchi; J Young; J R Jass; B A Leggett
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

7.  Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.

Authors:  Atsuko Yoshioka Higashi; Tomokatsu Ikawa; Masamichi Muramatsu; Aris N Economides; Akira Niwa; Tomohiko Okuda; Andrew J Murphy; Jose Rojas; Toshio Heike; Tatsutoshi Nakahata; Hiroshi Kawamoto; Toru Kita; Motoko Yanagita
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

8.  Identification of aneuploidy-selective antiproliferation compounds.

Authors:  Yun-Chi Tang; Bret R Williams; Jake J Siegel; Angelika Amon
Journal:  Cell       Date:  2011-02-18       Impact factor: 41.582

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.

Authors:  David T W Jones; Sylvia Kocialkowski; Lu Liu; Danita M Pearson; L Magnus Bäcklund; Koichi Ichimura; V Peter Collins
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

View more
  14 in total

1.  Upregulation of the Na⁺-coupled phosphate cotransporters NaPi-IIa and NaPi-IIb by B-RAF.

Authors:  Tatsiana Pakladok; Zohreh Hosseinzadeh; Aleksandra Lebedeva; Ioana Alesutan; Florian Lang
Journal:  J Membr Biol       Date:  2013-11-21       Impact factor: 1.843

2.  Deregulated ERK1/2 MAP kinase signaling promotes aneuploidy by a Fbxw7β-Aurora A pathway.

Authors:  Stéphanie Duhamel; Charlotte Girondel; Jonas F Dorn; Pierre-Luc Tanguay; Laure Voisin; Ron Smits; Paul S Maddox; Sylvain Meloche
Journal:  Cell Cycle       Date:  2016-05-06       Impact factor: 4.534

Review 3.  K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas.

Authors:  Nikolaos Margetis; Myrsini Kouloukoussa; Kyriaki Pavlou; Spyridon Vrakas; Theodoros Mariolis-Sapsakos
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

4.  Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling.

Authors:  Michael Röring; Ricarda Herr; Gina J Fiala; Katharina Heilmann; Sandra Braun; Anja E Eisenhardt; Sebastian Halbach; David Capper; Andreas von Deimling; Wolfgang W Schamel; Darren N Saunders; Tilman Brummer
Journal:  EMBO J       Date:  2012-04-17       Impact factor: 11.598

5.  Hyper-active RAS/MAPK introduces cancer-specific mitotic vulnerabilities.

Authors:  Jacob A Herman; Romario R Romain; Pia Hoellerbauer; Hazheen K Shirnekhi; David C King; Keith F DeLuca; Erin Osborne Nishimura; Patrick J Paddison; Jennifer G DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

6.  A double-edged sword: how oncogenes and tumor suppressor genes can contribute to chromosomal instability.

Authors:  Bernardo Orr; Duane A Compton
Journal:  Front Oncol       Date:  2013-06-27       Impact factor: 6.244

Review 7.  Aneuploidy in health, disease, and aging.

Authors:  Robin M Ricke; Jan M van Deursen
Journal:  J Cell Biol       Date:  2013-04-01       Impact factor: 10.539

8.  Hematopoietic expression of oncogenic BRAF promotes aberrant growth of monocyte-lineage cells resistant to PLX4720.

Authors:  Tamihiro Kamata; David Dankort; Jing Kang; Susan Giblett; Catrin A Pritchard; Martin McMahon; Andrew D Leavitt
Journal:  Mol Cancer Res       Date:  2013-10-23       Impact factor: 5.852

9.  The RAS GTPase RIT1 compromises mitotic fidelity through spindle assembly checkpoint suppression.

Authors:  Antonio Cuevas-Navarro; Richard Van; Alice Cheng; Anatoly Urisman; Pau Castel; Frank McCormick
Journal:  Curr Biol       Date:  2021-07-07       Impact factor: 10.900

10.  Up-regulation of hERG K⁺ channels by B-RAF.

Authors:  Tatsiana Pakladok; Zohreh Hosseinzadeh; Ahmad Almilaji; Aleksandra Lebedeva; Ekaterina Shumilina; Ioana Alesutan; Florian Lang
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.